01 1Suven Life Sciences Limited
01 1GABAPENTIN USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-05
Pay. Date : 2018-07-17
DMF Number : 17063
Submission : 2003-12-29
Status : Active
Type : II
20
Suven Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is GABAPENTIN USP, with a corresponding US DMF Number 17063.
Remarkably, this DMF maintains an Active status since its submission on December 29, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 05, 2018, and payment made on July 17, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
